Comparative actions of salicylate on the amphibian lateral line and guinea pig cochlea by Puel, Jean Luc et al.
Camp. Bmhem. Physiol. Vol. 93C, No. 1, pp. 73-80, 1989 
Printed in Great Britain 
0306~4492/89 $3.00 + 0.00 
0 1989 Pergamon Press plc 
COMPARATIVE ACTIONS OF SALICYLATE ON THE 
AMPHIBIAN LATERAL LINE AND GUINEA PIG 
COCHLEA 
JEAN Luc PUEL,* SANFORD C. BLEDSOE, JR,? RICHARD P. BoBBIN,*$ GAIL CEASAR* 
and MAUREEN FALLON* 
*Louisiana State University Medical School, Kresge Hearing Research Laboratory of the South, 
Department of Otorhinolaryngology, and Biocommunication, 2020 Gravier Street, Suite A, New Orleans, 
LA 70012, USA; and tKresge Hearing Research Institute, University of Michigan Medical School, 
Ann Arbor, MI 48109, USA. Telephone (504) 568-4785 
(Received 27 June 1988) 
Abstract-l. Salicylate actions on afferent nerve activity in the Xenopus lateral lme and on cochlear 
potentials in guinea pig were investigated. 
2. In the lateral line, salicylate (0.3-2.5 mM) suppressed spontaneous activity. water motion evoked 
excitation and responses to L-glutamate (l-2 mM) and kainate (lo-20 PM). 
3. In the guinea pig, salicylate (0.6-10 mM) suppressed the compound action potential (CAP) and 
increased Nl latency at low but not high sound intensities. 
4. In the lateral line salicylate action may involve an antagonism of the hair-cell transmitter on the 
afferent nerve. 
5. In the cochlea salicylate may suppress the active process or cochlear amplifier. 
INTRODUCTION 
For at least a century, it has been recognized that 
aspirin (acetylsalicylic acid) can cause tinnitus and 
hearing loss. The effects are completely reversible, 
usually 24-72 hr after stopping aspirin ingestion 
(Macht et al., 1920; McCabe and Dey, 1965; Mongan 
et al., 1973). The toxicity has been attributed to the 
salicylate ion since sodium salicylate produces a 
reversible increase in auditory threshold at con- 
centrations comparable to those present in blood 
following the administration of aspirin (Myers 
and Bernstein, 1965; Gold and Wilpizeski, 1966; 
Silverstein et al., 1967). 
To date, the literature cannot explain the precise 
nature of the hearing loss due to salicylate although 
the cochlea appears to be the primary site of 
action (Jastreboff and Sasaki, 1986). For example, 
Silverstein et al. (1967) reported that both the 
cochlear microphonic (CM) and the compound 
action potential of the auditory nerve (CAP) were 
depressed in cats following intraperitoneal injection 
of sodium salicylate. McPherson and Miller (1974) 
reported the same effect in guinea pigs following 
intragastric injection of choline salicylate. These re- 
sults suggest that the hair cells of the cochlea are 
affected by salicylate. On the other hand, Mitchell 
et al. (1973) observed only the decrease in CAP 
following subcutaneous administration of sodium 
salicylate to guinea pigs and concluded that salicylate 
affected the auditory nerve and not the hair cells. The 
results of Thalmann et al. (1973), Thalmann (1975) 
and Bobbin and Thompson (1978) which showed that 
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salicylate reduced the CAP without affecting CM, 
support this conclusion. 
The present study was designed to provide ad- 
ditional information about the effects of salicylate. 
We examined a hypothesis first suggested by Mitchell 
et al. (1973) that salicylate may have an action at the 
hair cell-afferent nerve synapse. Since L-glutamate 
appears to be the hair cell transmitter (Bledsoe et al., 
1988), we tested the effects of salicylate on responses 
to L-glutamate, spontaneous activity and water mo- 
tion induced excitation of afferent nerve fibers inner- 
vating hair cells in the lateral line of Xenopus laeuis. 
For a comparison and to determine if the results 
obtained in the lateral line could possibly account for 
the actions of salicylate in the cochlea we also 
examined the effects of salicylate on guinea pig 
cochlear potentials looking for actions which could 
be explained by an antagonism of the action of the 
hair cell transmitter. A preliminary report has been 
presented (Bobbin et al., 1985~). 
MATERIALS AND METHODS 
Lateral-line experiments were performed on adult male or 
female African clawed frogs, Xenopus laeris. The techniques 
for anesthetizing the animals, removing a portion of skin 
containing the lateral-line organ, the in vitro methods for 
isolating and recording afferent nerve activity from a single 
cluster of hair cells (stitch), and annlying drugs to the inner 
surface of the skin were as’previousiyhescribeed (Bledsoe and 
Bobbin. 1982: Bledsoe et al.. 1983: Bobbin er al.. 1985a. b). 
The posterior lateralis nerve trunk was dissected free from 
connective tissue and action potentials from the two afferent 
nerve fibers innervating a selected stitch were recorded 
extracellularly with a suction electrode, digitized and 
counted with a ratemeter in 30 set time bins. The inner 
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surface of the skin was continuously washed with frog Artificial perilymph solutions were infused into the basal 
Ringer solution at room temperature (2G23”C) except turn Scala tympani and allowed to flow out of the basal turn 
during periods of drug testing. The Ringer solution, which scala vestibuli at approximately 0.6 pl/min for 10min 
flowed at a rate of 2 ml/min, had the following composition 
(mM): NaCl, 110; KCl, 2.0; CaCI,, 1.8; NaiHP6,. 2.25; 
through holes made in the cochlea. The composition of the 
artificial perilymph was similar to that used previously 
NaH,PO,. 0.75: DH. 7.0. The oreoaration described bv 
Bobgin e; al. (1481j was used’ td study the effects o> 
(Bobbin and Ceasar, 1987) and had a composition of (mM): 
NaCI, 137; KCl, 5; CaCI,, 2; MgCl,, 1; Hepes, 1; glucose, 
salicylate on afferent nerve responses to glutamate and other 11; pH 7.4. The two drug solutions tested were sodium 
excitatory amino acids. Responses to agonists were obtained salicylate (salicylate) and for an osmotic control, alpha- 
during an initial drug-free Ringer wash, 40 min after starting ketoglutaqate. The salicylate and alpha-ketoglutarate were 
a wash containing salicylate and again 20-30 min after initially dissolved in artificial perilymph to make a 20 mM 
washing the preparation with the drug-free Ringer solution. concentration and the pH adjusted to 7.4. Dilutions were 
For each response, 2 min of spontaneous activity were then made to yield concentrations tested (mM): 20, 10, 5, 
recorded, then a 1 ml volume of agonist solution with or 2.5, 1.25, 0.625, 0.312 and 0.156. In all animals, artificial 
without salicylate was injected into the tube delivering the perilymph without drug was the first perfusion. This was 
Ringer wash. The activity before drug application was used then followed by successive perfusions with increasing con- 
to calculate a mean spontaneous firing rate. The difference centrations of the drug from 0.156 to 20 mM. All drug 
in the peak excitation elicited by an agonist and the pre-drug perfusions were followed by another 10 min perfusion with 
spontaneous level in the presence of salicylate was expressed artificial perilymph without drug. Intensity functions were 
as a percentage of that obtained in its absence. obtained before and immediately (within 2 min) after each 
perfusion. 
. 
The effects of sahcylate on water motion-induced re- 
sponses of the afferent nerve fibers were evaluated as 
previously described (Bledsoe and Bobbin, 1982; Bobbin 
et al.. 1985a, b). Isolated skins were held on the end of a 
plashc cylinder with a Neoprene O-ring and the external 
(cupular) surface of the skin facing down into a water-filled 
chamber. A glass rod attached to the cone of a loudspeaker 
was positIoned 0.5-l.Omm beneath a selected stitch and 
vibrated at a frequency of 35 Hz with a sinusoidal voltage. 
A microcomputer controlled stimulus on. off, and mag- 
nitude. Stimulus magnitude was set at 9dB above the 
threshold of excitation. Threshold was established with 
audiovisual cues and defined as the intensity needed to 
produce a just detectable increase m spontaneous discharge 
rate. For testing, the Ringer wash (with or without sahcyl- 
ate) was turned off and 3 alternating 30sec periods of 
spontaneous and stimulated activity were recorded in 
IO set time bins in the absence or presence of salicylate 
in 200~1 of Ringer solution placed in the experimental 
chamber to cover the inner surface of the skin. Mean 
spontaneous and stimulated firing rates were calculated 
from the second and third time bins m each of the 3 samples 
of spontaneous and stimulated activity. These values, as well 
as the difference between them, in the presence of salicylate 
were expressed as a percentage of those obtained in its 
absence. 
Cochlear experiments were performed on 12 pigmented 
guinea pigs, Curia cobaya, of either sex using methods 
similar to those previously described (Bobbin and Ceasar, 
1987). The animals were anesthetized with chlorprothixene 
(Taractan, 25 mg/kg, i.p.) and pentobarbital (Nembutal, 
30 mg/kg. l.p.), and artificially respired. During experi- 
ments, additional pentobarbital was adminstered (25 mg/kg, 
i.p.) to assure a deep level of anesthesia and rectal tempera- 
ture was maintained at 37-39°C. The right cochlea of each 
animal was exposed ventrolaterally and both middle ear 
muscles sectioned. 
The CAP (Nl -PI), Nl latency, CM and summating 
potential (SP) were recorded from a 200pm enamel- 
insulated silver wire placed m a hole m the Scala vestibuli of 
the basal turn, amplified, averaged (20 samples) and stored 
on a computer. The potentials were evoked by 10 kHz tone 
bursts having 0.25 msec exponential rise-fall times, 10 msec 
duration and 200 msec interstimulus interval. Intensity func- 
tions were obtained by varying tone burst intensities 
(2-104 dB SPL, in 6 dB steps). For measurement purposes, 
the stored voltages were directed into a filter with a low pass 
setting of 2 kHz for CAP, Nl latency and SP or a band pass 
of 7.1 to 15 kHz for CM, and the butput of the filter-was 
displayed on an oscilloscope. The threshold of CAP was 
define; as the dB SPL needed to elicit a measurable response 
(2 5 pV) which increased in magnitude with the next step 
increase in sound intensity. 
To quantify the effect of the salicylate, we carried out 
statistical tests on data obtained at: (1) a high sound 
intensity (98 dB SPL) before turnover of the CM potential, 
and (2) from a low intensity (62 dB SPL) which yielded 
potentials (CAP, Nl latency, CM and SP) after the drug 
treatment which were above the noisd of the recording 
system. Analysis of variance and Newmann-Keuls multiple 
range tests were used to determine significance (P < 0.01). 
The data are expressed as mean + SE. 
RESULTS 
In the lateral line salicylate blocked spontaneous 
activity and the increase in afferent nerve activity 
evoked by L-glutamate and kainic acid in a dose 
responsive manner (Fig. 1; Table 1). The lowest 
concentration to have an antagonist effect was 
0.30 mM whereas at 2.5 mM salicylate totally abol- 
ished spontaneous activity and the responses to gluta- 
mate and kainate. Water motion induced increases in 
afferent activity were more resistant to the blocking 
actions of salicylate. Salicylate at concentrations up 
to 1.25 mM reduced spontaneous activity without a 
marked suppressive effect on evoked activity (Fig. 2; 
Table 2) whereas 2.5 mM abolished both spon- 
taneous and evoked activity (Fig. 2; Table 2). At 
2.5 mM the effects of salicylate were partially 
reversible. 
In the guinea pig cochlea the initial perfusion 
solution in each animal was artificial perilymph with- 
out drug. This perfusion produced a very small 
change in the cochlear potentials whereas subsequent 
perfusions with the same solution resulted in little 
additional change. Thus all drug effects are compared 
to potentials recorded after the first perfusion. 
Artificial perilymph solutions containing salicylate 
induced a dose response suppression of the sound 
evoked CAP, increased Nl latency at a given low 
intensity and did not affect CM or SP (Figs 3 and 4). 
The only significant change on CAP threshold with 
alpha-ketoglutarate occurred at 20 mM whereas with 
salicylate the CAP threshold was raised significantly 
beginning at concentrations of 0.6mM (Table 3). 
In addition, the Nl latency at the CAP threshold 
was significantly decreased by salicylate but not 
by alpha-ketoglutarate (Table 3). The effect of 
salicylate on CAP threshold responses was obtained 
by subtracting the threshold change produced by 
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Fig. 1. Responses of lateral line afferent fibers to exogenously applied L-glutamate (L-GLU) and 
kainate (KA) in the presence of 0.3 mM, 1.25 mM and 2.5 mM sahcylate. Results are from 3 different 
experiments. 
Table 1. Depression* of amino acid Induced excitation and spontaneous activity by 
salicylate 
Salicylate Spontaneous Ammo acid-induced 
concentration actiwty activity (%) 
(nW (%) GLU (1-2 mM) KA (l&20 HIM) 
0.3 37+4 35 f 36 46k 17 
n=6 ?I=5 n=3 
0.6 65f 11 57* IO 59+11 
n=4 n=4 n=4 
1.25 87 f 5 78+15 94 f 1 
n=2 n=2 II=2 
2.5 IOOzbl 87* 11 92 + 3 
n=3 n=3 n=3 
*Represented is the percentage (mean + SE) reduction from preblocker responses. 
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Fig. 2. Effect of 1.25 mM and 2.5 mM salicylate (salicylate) 
on spontaneous activity and water motion-induced exci- 
tation of lateral line afferent nerve fibers. Shown are results 
from two preparations (top and bottom panels) obtained in 
the presence of 200 ~1 of drug-free Ringer solution, 40 min 
after washing the preparation with salicylate, and again 
30min after a drug-free Ringer wash. An initial 30sec of 
spontaneous activity followed by three alternating 30 set 
periods of stimulated and spontaneous activity were 
recorded in 10 set time bins. Stimulus intensity was 9 dB re 
threshold. 
alpha-ketoglutarate from the change produced by 
salicylate (Table 3). The data in Table 3 reveal the 
maximum effect of salicylate occurred at about 
5 mM. 
Statistical examination revealed that salicylate 
significantly reduced the magnitude of the CAP 
evoked by low intensity tone bursts (62dB SPL) 
in concentrations beginning at 1.25 mM (Fig. 4). 
Table 2. Effects of salicylate on spontaneous activity and water 
motion-Induced excitation 
Sahcylate water 
Apphcatlon concentration Spontaneous Motion-induced 
techmque (mM) (%) (%) 
Wash I .25 -73F4 +1.8*7 - 
n=5 n=5 
Wash 2.5 -100~0 -95k2 
n=4 n=4 
2cO/ll I 25 -42k5 +31*4 
n=7 n=7 
2oopl 2.5 -73f4 -2lk5 
n=4 ?I=4 
Results are expressed as the percentage (mean _+ SE) change from 
preblocker responses, (+) denotes enhancement and (-) sup- 
pression. 
Water motion-induced activity obtamed at 9 dB above threshold as 
described in methods. Salicylate was applied in the Ringer wash 
for 40 mm or as a 200~1 volume which remained in the 
experimental chamber for 40 min prior to testing. 
However, salicylate had no effect on CAP magnitude 
evoked by high-intensity tone bursts (98 dB SPL, not 
shown but see Fig. 3). In comparison alpha-ketoglu- 
tarate which only affected CAP at 20 mM, reduced 
responses to both low (Table 3) and high intensity 
tone bursts. Nl latency at a given low sound intensity 
(62 db SPL) was significantly increased by salicylate 
beginning at 2.5 mM (Fig. 4). Consistent with the 
CAP amplitude data, Nl latency at a given high 
intensity (98 dB SPL) was not affected by salicylate 
(not shown but see Fig. 3). The control, alpha- 
ketoglutarate, did not affect Nl latency (Fig. 4). The 
SP to low intensity tone bursts (62 dB SPL) was 
significantly reduced by high concentrations of both 
salicylate (10 and 20 mM) and alpha-ketoglutarate 
(20 mM) (Fig. 4). In contrast, neither salicylate nor 
alpha-ketoglutarate significantly changed SP evoked 
by high-intensity (98 dB SPL) sound. The CM to 
both low- (62 dB SPL; Fig. 4) and high- (98 dB SPL) 
intensity tone bursts was not significantly altered by 
either salicylate or alpha-ketoglutarate. All these 
changes exhibited a partial recovery after a final 
perfusion with artificial perilymph without drug 
(Fig. 4). 
In two animals recovery was examined after a 
single perfusion of 5 mM salicylate. In both animals 
the salicylate induced a suppression of the CAP 
similar to that obtained with 5 mM salicylate in the 
cumulative salicylate paradigm. Subsequent per- 
fusion of artificial perilymph induced a complete 
recovery of the CAP. 
DISCUSSION 
In the lateral line salicylate suppressed spon- 
taneous activity and responses to L-glutamate and 
kainate in a dose responsive manner. In higher 
concentrations, yet at the same concentration that 
was required to completely block L-glutamate and 
kainate, salicylate antagonized the effect of natural 
stimulation (i.e. water motion). These results support 
the hypothesis that salicylate antagonizes the hair cell 
transmitter. The observation that higher concen- 
trations of salicylate were necessary to block natural 
stimulation than was necessary to antagonize the 
effects of exogenously applied L-glutamate is com- 
mon in the study of neurotransmitter antagonists 
(Davies et al., 1984, 1986). On the other hand, this 
could indicate that the effect of salicylate was due to 
a nonselective mechanism such as blockade of an 
ion channel. Unfortunately, we could not test the 
selectivity of the glutamate block since other exci- 
tatory substances in the lateral line either act on 
L-glutamate receptors or on acetylcholine receptors, 
the latter which appear to act through the release 
of L-glutamate, the putative hair cell transmitter 
(Bobbin et al., 1985b). 
Cochlear perfusion of salicylate resulted in a dose 
responsive suppression of CAP and an increase in Nl 
latency which were not observed with the same 
concentrations of alpha-ketoglutarate. This indicates 
that the actions of salicylate were not due to non- 
specific physical alterations in the cochlea such 
as might be brought about by osmotic effects. In 
addition, the concentrations of salicylate found 














24 44 64 84 Id4 





















44 s4 84 104 
$4 44 84 104 
Intensity (dB SPL) 
Frg. 3 Effect of salicylate on CAP, Nl latency, CM and SP inputoutput functions evoked by 10 kHz 
tone-bursts. Shown are input-output functions obtained before any perfusion (O), after perfusion with 
artificial perilymph alone before drug ([I). and after perfusing IOmM salicylate (0). 
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Fig. 4. Effect of increasing concentrations of salicylate (black bars; n = 5) and alpha-ketoglutarate (white 
bars; n = 5) on the CAP, Nl latency, SP and CM. Shown are the data evoked by tone bursts of 62 dB 
SPL before any perfusions (B) and after perfusion with artificial perilymph along before drug (A), 
successive perfusions of increasing concentrations of salicylate: 0.15 mM (1); 0.3 1 mM (2); 0.62 mM (3); 
1.25 mM (4); 2.5 mM (5); 5 mM (6); 10 mM (7); 20 mM (8), and a post drug artificial perilymph (R). 
Asterisks indicate a statistically (P -c 0.01) significant difference from the value obtained after perfusion 
with artificial perilymph alone before drug (A). 
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Table 3. Effects of salicylate and alpha-ketoglutarate (control) on the CAP threshold (dB) and NI latency 
(msec) measured at CAP threshold in the guinea pig 
Control Control Salicylate Salicylate s-c 
mM dB’ msect dB* msect dBi 
Art. pen. 0 f 0.00 
0.15 1.2 f 1.20 
0.3 - 2.4 f 2.40 
0.6 -1.2k2.94 
I 25 o+ 1.90 
2 50 0 i 4.24 
5 - 1.2 i 3.98 
IO 3.6 + 5.88 
20 13 2 + 6.946 
3.38 + 0.058 
3.36 f 0.043 
3.45 * 0.045 
3.41 * 0.037 
3.37 + 0.058 
3.34 + 0.029 
3.40 * 0.047 
3.29 + 0.081 
3.21 f 0.056 
0 f 0.00 
2.4 + I .47 
6+ 1.90 
I2 * I.905 
18 + 1.90$ 
28.8 + 2.2% 
38.4 + 2.405 
43.2 f 3.985 
54 f 4.906 
3.43 + 0.060 0 
3.37 * 0.030 1.2 
3.41 + 0.064 8.4 
3 30 + 0.042 13.2 
3.27 + 0.034 I8 
3.21 k 0.078 28.8 
3.00 f 0.0475 39.6 
2.94 + 0.0515 39.6 
2.86 + 0.0666 40.8 
‘Numbers represent the dB values (mean + SE) obtained by subtracting the mean CAP threshold after each 
treatment from the mean CAP threshold after the predrug artificml perilymph perfusion (art. peri.; n = 5 
except for 20 mM control where n = 4). 
tNumber represent the NI latency values (mean + SE) measured at CAP threshold after each treatment 
(n = 5 except for 20 mM control where n = 4). 
fControl dB values subtracted from sahcylate dB values to arrive at the effect of salicylate without apparent 
non-selective effects. 
§Indlcate a statlstlcally (P < 0.01) sigmficant difference from the value obtamed for artificial @lymph (art. 
peri.) or 0.15 mM of drug. 
same as the concentrations found in the cochlea after 
systemic administration of aspirin to achieve a blood 
level necessary to produce a hearing loss (Jastreboff 
et al., 1986; Thalmann, 1988). 
The slight changes in SP and CM were produced 
by both chemicals only at 10 and 20 mM indicating 
nonspecific osmotic effects at high concentrations as 
reported earlier with alpha-ketoglutarate (Jenison 
et al., 1986). The results on SP and CM are consistent 
with the lack of effect of salicylate on CM reported 
by Mitchell et al. (1973), Thalmann et al. (1973) and 
Thalmann (1975), but are inconsistent with the 
reduction in CM reported by Silverstein et al. (1967). 
The SP and CM emanate from hair cells (Dallos, 
1985a, b 1986) and reflect the state of these pre- 
synaptic elements. The lack of effect of salicylate on 
SP and CM at low concentrations (less than 10 mM) 
indicates a postsynaptic site of action. 
The lack of effect on SP and CM is also consistent 
with salicylate not affecting the endocochlear poten- 
tial since a change in the endocochlear potential 
would be expected to decrease CM and SP (Bobbin 
and Kisiel, 1981). Thalmann et al. (1973) and Thal- 
mann (1975) first showed that salicylate did not affect 
the endocochlear potential. In addition, they were the 
first to point out that one of the proposed mecha- 
nisms of action of salicylate in other systems-an 
interference with energy metabolism (Ferreira and 
Vane, 1974would not explain the action of salicyl- 
ate in the cochlea because one of the most sensitive 
cochlear structures to antimetabolites is the stria 
vascularis and the endocochlear potential it gener- 
ates. For example, dinitrophenol (DNP) perfused 
into the cochlea produces rapid reduction in the 
endocochlear potential and CM with a concomitant 
reduction in the CAP (Thalmann et al., 1973; Thal- 
mann, 1975). Therefore we concur with Thalmann 
and conclude that one can exclude an action on 
energy metabolism as a mechanism of action for 
salicylate in the cochlea. 
One result obtained in the guinea pig cochlea 
appears to argue against the hypothesis that salicylate 
antagonizes the hair cell transmitter in this organ. 
Our data show that salicylate disrupts the normal two 
slope pattern of the CAP input-output function: 
abolishing the segment to low intensity sounds with 
no effect on the higher intensity segment. The results 
are consistent with the observations of Thalmann 
(1975) who reported similar changes in the shape of 
the CAP input-output function with intraperitoneal 
injection of 350 mg/kg of salicylate. They contrast, 
however, with those obtained with kynurenic acid, 
a glutamate antagonist. Kynurenic acid perfused 
through the guinea pig cochlea reduces CAP ampli- 
tude at all sound intensities resulting in a parallel shift 
in the CAP input-output function (Bobbin and 
Ceasar, 1987). A parallel shift is consistent with an 
antagonism of the hair cell transmitter since one 
would predict that the transmitter would be antago- 
nized at all sound levels. This difference between the 
affects of salicylate and kynurenic acid on the CAP 
input-utput curve then leads us to question whether 
salicylate in the cochlea antagonizes the hair cell 
transmitter, and suggests that we search for an alter- 
native explanation for the mechanism of action for 
salicylate in the cochlea. 
Traditionally the CAP to low-intensity sounds in 
the cochlea which salicylate abolished has been de- 
scribed as the most sensitive portion of the CAP 
input-output curve since it is the first part of the 
curve suppressed by intense sound (Salt et al., 1981) 
and toxic substances (Aran, 1981; Dallos, 1973). 
Most evidence indicates that the low intensity CAP 
reflects the summed activity of single afferent fibers 
firing at their most sensitive regions to sound stimu- 
lation. This region is known as the tip or nonlinear 
portion of the single afferent fiber tuning curve 
(Ozdamar and Dallos, 1976). Like the low intensity 
portion of the CAP curve, the nonlinear portion of 
the single unit tuning curve is also more sensitive to 
drugs (Evans and Klinke, 1974), anoxia (Evans, 1974) 
and intense sound (Cody and Johnstone, 1981). In a 
study of salicylate on single afferent fiber activity, 
Evans et al. (1981) and Evans and Borerwe (1982) 
reported systematic changes in the characteristics of 
three primary fibers recorded from three cats follow- 
ing intravenous injection of sodium salicylate. They 
observed about a 25 dB loss in sensitivity at the 
characteristic frequencies accompanied by a gradual 
loss of sharpness in the tip of the tuning curves. Thus 
the action of salicylate at the level of the CAP and at 
the level of the single afferent nerve fiber is the same: 
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abolishment of the low intensity portion of the CAP 
input-output function and abolishment of the single 
nerve tuning at low intensity. Recently it has been 
hypothesized that the nonlinear portion of the tuning 
curves and so the low intensity portion of the CAP 
input&output function reflect an active process (coch- 
lear amplifier) within the cochlea which is required 
for achieving its sensitivity and frequency selectivity 
(Davis, 1983; Kim, 1986). Thus it appears to us that 
in the cochlea the mechanism of action of salicylate 
involves an action on the active process iteself 
through an unknown molecular mechanism (e.g. 
prostaglandin synthesis) or to somehow interfere with 
its expression at the level of the nerve fibers. Other 
observations are consistent with this hypothesis. 
Aspirin consumption in humans and animals reduces 
delayed evoked otoacoustic emissions (Long et al., 
1986; Martin et al., 1988) and reversibly eliminates 
spontaneous emissions (McFadden and Plattsmeir, 
1984; Martin et al., 1988) which appear to depend on 
an intact active process in the cochlea. Since there is 
no evidence for an active process in the lateral line it 
is reasonable that no such action was detected in the 
lateral line. In addition, it is possible that in the 
cochlea the active process is more sensitive to salicyl- 
ate than the hair cell transmitter. Along these lines the 
active process is thought to be located with the outer 
hair cells and diffusion of salicylate to this site would 
seem to be more easily achieved than diffusion to the 
hair cell transmitter receptor located at the base of 
the inner hair cells. If this is the case and we could 
investigate higher concentrations of salicylate, poss- 
ibly by increasing the perfusion rate, we predict that 
a kynurenic acid-like action would be observed (i.e. 
a reduction in both the high and low intensity CAP) 
which would indicate an action on the hair cell 
transmitter. Future experiments will explore this 
possibility. 
The increase in Nl latency with salicylate has not 
been reported previously and was characterized by a 
shift towards higher intensity at low intensity tone 
bursts in the latency/intensity function, no change in 
the Nl latency of CAP evoked by high intensity tone 
bursts and a shortening of Nl latency at the CAP 
threshold. We propose that as with our results with 
the CAP magnitude, all of these changes in Nl 
latency are consistent with increasing amounts of 
salicylate decreasing and eventually abolishing the 
active process or the cochlear amplifier (Davis 1983; 
Kim, 1986). Davis’s model (1983) states that in the 
normal condition the “. . prolongation of latency 
near threshold beyond what can be explained by the 
rise time of the stimulus and the traveling wave 
delay . . .” is due to the extra time required for the 
cochlear amplifier resonator “. . . to build up to a full 
amplitude . .“. In addition, he implies that as sound 
intensity increases the latency becomes shorter, in 
part due to the major site of cochlear partition 
motion and so nerve fiber activation shifting basal- 
ward on the partition from the site of the cochlear 
amplifier and a dependence on the cochlear amplifier 
towards a dependence on the passive traveling wave 
with its shorter latency. Therefore, it appears that the 
shorter Nl latency at CAP threshold observed after 
high concentrations of salicylate are consistent with 
salicylate having abolished the cochlear amplifier of 
Davis’s model, and so abolishing the prolonged 
latency occurring at threshold which reflects the 
latency time required by the resonator of the cochlear 
amplifier. The fact that Nl latency at CAP threshold 
changes only slightly or not at all at low concen- 
trations of salicylate can be explained by salicylate 
only suppressing the cochlear amplifier and so leaving 
it partially operative. In contrast, the salicylate in- 
duced longer Nl latency at a given low intensity or 
the shift towards higher intensity of the latency- 
intensity function at low intensity (Fig. 3) is difficult 
to explain at the present time. When this latency 
phenomena was observed after intense sound ex- 
posure, we hypothesized that the abolishment of the 
cochlear amplifier slowed the rate of travel of the 
traveling wave (Puel et al., 1988). We speculate that 
this also explains the present phenomena observed 
after salicylate. The lack of effect of high concen- 
trations of salicylate on the Nl latency evoked by 
high intensity tone bursts is consistent with: (1) the 
dominance, at high intensity, of the passive traveling 
wave over the cochlear amplifier which according to 
the Davis model saturates at about 45 dB above 
threshold and, (2) a lack of effect of salicylate on the 
passive traveling wave and all the cochlear functions 
associated with it. Thus it appears that in the cochlea 
all of the actions of salicylate can be explained by an 
action on the active process or cochlear amplifier of 
Davis or an action which somehow interferes with its 
expression at the level of the nerve fibers or the CAP 
and Nl latency. 
In summary, in the lateral line salicylate suppresses 
spontaneous afferent fiber activity, water motion 
(natural) evoked activity and the action of L-gluta- 
mate and kainate. In the guinea pig, salicylate re- 
versibly suppresses CAP and increases Nl latency at 
low but not high sound intensities without a de- 
tectable affect on CM and SP. We conclude that the 
mechanism for this action of salicylate may be 
different in the two animals. In the lateral line the 
drug may act on the afferent nerve to antagonize the 
action of the afferent transmitter. In the guinea pig 
the drug appears to affect the active process and not 
the afferent transmitter. Whether higher concen- 
trations of salicylate in the guinea pig will produce an 
effect which resembles that of hair cell transmitter 
antagonists will be tested in future experiments. 
Acknowledgements-Thanks to Cindy Frazier for her aid in 
the preparation of this manuscript. This work was sup- 
ported at Kresge New Orleans by NSF research grant 
BNS-8419241 and the Louisiana Lions Eye Foundation and 
at Kresge Michigan by Program Project Grant USPHS 
NS-05785. 
REFERENCES 
Aran J.-M. (1981) Electrophysiology of cochlear toxicity. 
In Aminoglycoside Ototoxicity (Edited by Lemer S. A., 
Matz G. J. and Hawkins J. E.), pp. 31-47. Little, Brown 
& Co., Boston. 
Bledsoe S. C., Jr and Bobbin R. P. (1982) Effects of 
D-a-aminoadipate on excitation of afferent fibers in the 
lateral line of Xenopus laevis. Neurosci. L-en. 32,315-320. 
Bledsoe S. C., Jr, Bobbin R. P. and Puel J.-L. (1988) 
Neurotransmission in the inner ear. In Physiology of 
Hearing (Edited by Jahn A. F. and Santos-Sacchi J. R.), 
pp. 385406. Raven Press, New York. 
80 JEAN Luc PUEL et al. 
Bledsoe S. C., Jr, Chihal D. M., Bobbin R. P. and Morgan 
D. N. (1983) Comparative actions of glutamate and 
related substances on the lateral line of Xenopus laeuis. 
Comp. Biochem. Physiol. 75C, 119-206. 
Bobbin R. P. and Ceasar G. (1987) Kynurenic acid and 
gamma-o-glutamyl-aminoethylsulfonic acid suppress the 
compound action potential of the auditory nerve. Hear. 
Res. 25, 77-8 1. 
Bobbin R. P. and Kisiel D. L. (1981) Physiology of hearing. 
In Pharmacology of Hearrng (Edited by Brown R. D. 
and Daigneault E. A.), pp. 231-270. John Wiley, New 
York. 
Bobbin R. P. and Thompson M. H. (1978) Effects of 
putative transmitters on afferent cochlear transmission. 
Ann. 0101. Rhinol. Laryngol. 87, 185-190. 
Bobbin R. P., Bledsoe S. C.. Jr and Ceasar G. (198%) 
Action of salicylate on the activity of afferent fibers in the 
Xenopus laevis lateral line. Sot. Neurosci. 11, 244. 
Bobbin R. P., Bledsoe S. C.. Jr. Chihal D. M. and Morgan 
D. N. (1981) Comparative actions of glutamate and 
related substances on the Xenopus laeuis lateral line. 
Camp. Btochem. Physiol. 69C, 1455147. 
Bobbin R. P., Bledsoe SC., Jr, Wmbery S. L. and Jenison 
G. L. (1985a) Actions of putative neurotransmitters and 
other relevant compounds on Xenopus iaeuis lateral line. 
In Auditory Biochemistry (Edited by Dreschen D. G.), 
pp 102-122. Thomas, Springfield, Illinois. 
Bobbin R. P., Bledsoe S. C., Jr, Winbery S., Ceasar G. and 
Jenison G L. (1985b) Comparative acttons of GABA and 
acetylcholine on the Xenopus iaeois lateral line. Comp. 
Blochem. Physiol. 8OC, 3 13-3 18. 
Cody A. R. and Johnstone B. M. (1981) Acoustic trauma: 
single neuron basts for the “half-octave shift”. J. Acoust. 
Sot Am. 70, 7077719. 
Dallos P (1973) The Auditory Periphery: Biophysics and 
Physrology, pp. 365-366. Academic Press, New York. 
Dallos P. (1985a) Response characteristics of mammalian 
cochlear hair cells. J. Neuroscr. 5, 1591-1608. 
Dallps P. (1985b) The role of outer hair cells in cochlear 
function. In Contemporary Sensory Neurobiology (Edited 
by Correia M. J. and Perachio A. A.), pp. 207-230. Liss, 
New York. 
Dallos P. (1986) Neurobiology of cochlear inner and outer 
hair cells: Intracellular recordings. Hear. Res. 22, 
185-198. 
Davies J., Jones A. W., Sheardown M. J., Smith D. A. S. 
and Watkms J. C. (1984) Phosphono dipeptides and 
piperazine derivatives as antagonists of amino acid- 
Induced and synaptic excitation in mammalian and 
amphibian spinal cord. Neurosci. Left. 52, 79-84. 
Davies J., Miller A. J. and Sheardown M. J. (1986) Amino 
acid receptor mediated excitatory synaptic transmission in 
the cat red nucleus. J. Physioi. 376, 13-29. 
Davis H. (1983) An active process in cochlear mechanics. 
Hear. Res. 9, 79-90. 
Evans E. F. (1974) The effects of hypoxia on the tuning of 
single cochlear nerve fibers. J. Physiol. 238, 65-67. 
Evans E. F. and Borerwe T. A. (1982) Ototoxic effects of 
salicvlates on the responses of sinale cochlear nerve fibres 
and bn cochlear potentials. Br. .f Audiol. 16, 101-108. 
Evans E. F. and Klinke R. (19741 Reversible effects of 
cyanide and furosemide on t~he tuning of single cochlear 
nerve fibers. J. Physrol. 242, 129-131. 
Evans E. F., Wilson J. P. and Borerwe T. A. (1981) Animal 
models of Tinnitus. In CIBA Foundation Symposium 85, 
Tinnitus, pp. 108-129. Pitman, London. 
Ferreira S. H. and Vane J. R. (1974) New aspects of the 
mode of action of nonsteroid anti-inflammatory drugs. A. 
Ret. Pharmac. 14, 57-73. 
Gold A. and Wilpizeski C. R. (1966) Studies in auditory 
adaptation. II: some effects of sodium salicylate on 
evoked auditory potentials in cats. Laryngoscope 76, 
674-685. 
Jastreboff P. J., Hansen R., Sasaki P. G. and Sasaki C. T. 
(1986) Differential uptake of salicylate in serum, cerebro- 
spinal fluid, and perilymph. Arch. Otoiaryngol. Head 
Neck Surg. 112, 1050-1053. 
Jastreboff P. J. and Sasaki C. T. (1986) Salicylate-induced 
changes in spontaneous activity of single units in the 
inferior colliculus of the guinea pig. J. Acousf. Sot. Am. 
80, 1384-1391. 
Jemson G. L., Winbery S. and Bobbin R. P. (1986) 
Comparative actions of quisqualate and N-methyl-o-as- 
partate, excitatory amino acid agonists, on guinea pig 
cochlear potentials. Comp. Biochem. Physiol. MC, 
385389. 
Kim D. 0. (1986) Active and nonlinear cochlear bio- 
mechanics and the role of outer-hair-cell subsystem 
in the mammalian auditory system. Hear. Res. 22, 
105-l 14. 
Long G. R.. Tubis A. and Jones K. (1986) Changes in 
spontaneous and evoked otoacoustic emissions and corre- 
sponding psychoacoustic threshold microstructures in- 
duced by aspirin consumption. In Perrpheral Auditory 
Mechanisms (Edited bv Allen J. G.. Hall J. L.. Hubbard 
A.. Neely S.‘T. and Tubis A.), pp. 213-220.’ Springer- 
Verlag, New York. 
Macht D. I., Greenberg J. and lsaacs S. (1920) The effect 
of some antipyretics on the acuity of hearmg. J. Pharm. 
exp. Ther. 1s; 1499165. 
Martin G. K.. Lonsburv-Martin B. L.. Probst R. and Coats 
A. C. (1988) Spontaneous otoacoustic emissions in a 
nonhuman primate. I. Basic features and relations to 
other emissions. Hear. Res. 33, 49968. 
McCabe P. A. and Dey F. L. (1965) The effect of aspirin 
upon auditory sensitivity. Ann. Otol. 74, 312-325. _ 
McFadden D. and Plattsmier H. S. (1984) Asnirin abolishes 
spontaneous oto-acoustic emissions. J: Acbust. Sot. Am. 
76, 443-447. 
McPherson D. L. and Miller J. M. (1974) Choline salicylate: 
effects on cochlear function. Arch. Ofoiaryngol. 99, 
305-308. 
Mitchell C.. Brummett R., Himes D. and Vernon J. (1973) 
Electra-physiological study of the effect of sodium salicy- 
late upon the cochlea. Arch. Otoiaryngol. 98, 297-301. 
Mongan E., Kelly P., Nies K., Porter W. W. and Paulus 
H. E. (1973) Tinnitus as an indicator of therapeutic serum 
salicylate levels. JAMA 226, 142-145. 
Myers E. N. and Bernstein J. M. (1965) Salicylate oto- 
toxicity. Arch. Otolaryngol. 82, 483-493. 
Ozdamar 0. and Dallas P. (1976) Input-output function of 
the cochlear whole-nerve action potentials: interpretation 
in terms of one populate of neurons. J. Acoust. Sot. Am. 
59, 143-147. 
Puel J. L., Bobbin R. P. and Fallon M. (1988) The active 
process is affected first by intense sound exposure. Hear. 
Res. (submitted). 
Salt A. N., Konishi T., Cook R. 0. and Akay A. (1981) 
Comparison between the effects of continuous and impact 
noise on cochlear potentials in guinea pigs. J. Acousr. Sot. 
Am. 69, 1746-1752. 
Silverstein H., Bernstein J. M. and Davtes D. G. (1967) 
Salicylate ototoxicity: a biochemical and electrophysio- 
logical study. Ann. Otol. Laryngoi. 76, 118-127. 
Thalmann R. (1975) Biochemical studies of the auditory 
system. In The Nervous System. Vol. 3: Human Communi- 
cation and Its Disorders (Edited by Tower D. B.), 
pp. 31-44. Raven Press, New York. 
Thalmann R. (1988) Personal communication. 
Thalmann R., Miyoshi T., Kusakari J. and Thalmann I. 
(1973) Quantitative approaches to the ototoxicity prob- 
lem. Audiology 12, 364-382. 
